Can volume indices of total, free, and complex prostate-specific antigen enhance the prediction of the pathologic stage of clinical T1C prostate cancer?

被引：0
|
作者：
Naya, Y
Fritsche, HA
Stamey, TA
Cheli, CD
Partin, AW
Sokoll, LL
Chan, DW
Brawer, MK
Taneja, SS
Lepor, H
Bartsch, G
Childs, S
Babaian, RJ
机构：
来源：
JOURNAL OF UROLOGY | 2003年 / 169卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1137
引用
收藏
页码：293 / 293
页数：1
相关论文
共 50 条
  • [21] Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: A prospective multicenter clinical trial
    Southwick, PC
    Catalona, WJ
    Partin, AW
    Slawin, KM
    Brawer, MK
    Flanigan, RC
    Patel, A
    Richie, JP
    Walsh, PC
    Scardino, PT
    Lange, PH
    Gasior, GH
    Parson, RE
    Loveland, KG
    JOURNAL OF UROLOGY, 1999, 162 (04): : 1346 - 1351
  • [22] Prostate-specific antigen adjusted for the transition zone volume versus free-to-total prostate-specific antigen ratio in predicting prostate cancer
    Moon, DG
    Cheon, J
    Kim, JJ
    Yoon, DK
    Koh, SK
    INTERNATIONAL JOURNAL OF UROLOGY, 1999, 6 (09) : 455 - 462
  • [23] Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1c carcinoma of the prostate
    Presti, JC
    Hovey, R
    Carroll, PR
    Shinohara, K
    JOURNAL OF UROLOGY, 1996, 156 (05): : 1685 - 1690
  • [24] Analysis of T1c prostate cancers treated at very low prostate-specific antigen levels
    Kaplan, Mustafa
    Arda, Ersan
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2009, 8 (01): : 16 - 19
  • [25] Using proportions of free to total prostate-specific antigen, age, and total prostate-specific antigen to predict the probability of prostate cancer
    Chen, YT
    Luderer, AA
    Thiel, RP
    Carlson, G
    Cuny, CL
    Soriano, TE
    UROLOGY, 1996, 47 (04) : 518 - 524
  • [26] Role of prostate-specific antigen velocity in prediction of final pathologic stage in men with localized prostate cancer
    Thiel, R
    Pearson, JD
    Epstein, JI
    Walsh, PC
    Carter, HB
    UROLOGY, 1997, 49 (05) : 716 - 720
  • [27] Analysis of T1c Prostate Cancers Treated at Very Low Prostate-Specific Antigen Levels
    Stephenson, Andrew J.
    Jones, J. Stephen
    Hernandez, Adrian V.
    Ciezki, Jay P.
    Gong, Michael C.
    Klein, Eric A.
    EUROPEAN UROLOGY, 2009, 55 (03) : 610 - 616
  • [28] Inadequacy of free prostate-specific antigen parameters in the prediction of pathologic extent of prostate cancer in Japanese men
    Egawa, S
    Suyama, K
    Soh, S
    Kuwao, S
    Uchida, T
    Koshiba, K
    UROLOGY, 1998, 52 (02) : 230 - 236
  • [29] The ratio of free to total prostate-specific antigen in serum is correlated to the prostate volume
    Stephan, C
    Jung, K
    Lein, M
    Schnorr, D
    Loening, SA
    INTERNATIONAL JOURNAL OF CANCER, 1996, 67 (03) : 461 - 462
  • [30] Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: A prospective multicenter clinical trial - Comment
    Crawford, ED
    JOURNAL OF UROLOGY, 1999, 162 (04): : 1351 - 1351
12345